Showing results (41-50 of 63) with videos related to
Sort By:
Pageof 7
Cell Host & Microbe|March 11, 2016
Type I Interferon Signaling Prevents IL-1β-Driven Lethal Systemic Hyperinflammation during Invasive Bacterial Infection of Soft TissueVirginia Castiglia, Alessandra Piersigilli, Florian Ebner, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 17, 2015
The MAPK-Activated Kinase MK2 Attenuates Dendritic Cell-Mediated Th1 Differentiation and Autoimmune EncephalomyelitisKlara Soukup, Angela Halfmann, Marie Le Bras, et al.Blood|August 8, 2008
Leukemic challenge unmasks a requirement for PI3Kdelta in NK cell-mediated tumor surveillanceEva Zebedin, Olivia Simma, Christian Schuster, et al.Oncoimmunology|November 22, 2012
Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillanceTatsuaki Mizutani, Nina Neugebauer, Eva M Putz, et al.Blood Advances|July 5, 2019
STAT3β is a tumor suppressor in acute myeloid leukemiaPetra Aigner, Tatsuaki Mizutani, Jaqueline Horvath, et al.Nature Methods|August 7, 2012
A mouse model to identify cooperating signaling pathways in cancerMonica Musteanu, Leander Blaas, Rainer Zenz, et al.Frontiers in Immunology|July 22, 2024
STAT3 in acute myeloid leukemia facilitates natural killer cell-mediated surveillanceAgnieszka Witalisz-Siepracka, Clio-Melina Denk, Bernhard Zdársky, et al.International Journal of Cancer|August 14, 2019
JAK-STAT inhibition impairs K-RAS-driven lung adenocarcinoma progressionJulian Mohrherr, Marcel Haber, Kristina Breitenecker, et al.Blood|September 1, 2011
The cooperating mutation or "second hit" determines the immunologic visibility toward MYC-induced murine lymphomasChristian Schuster, Angelika Berger, Maria A Hoelzl, et al.Medicine|December 31, 2015
Impact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas: A Retrospective Cohort StudyAna-Iris Schiefer, Christoph Kornauth, Ingrid Simonitsch-Klupp, et al.Pageof 7